Dr. Markandeya Gorantla

Dr. Gorantla is Executive Chairman and Managing Director of ATGC Biotech Pvt. Ltd & Co-founder & CTO of ISCA Inc. USA. ATGC Biotech Private Limited is a pioneering force in the field of semiochemicals and synthetic biology-based pheromone production. With a vision to create a pesticide-free world, ATGC is embarking on a transformative journey through its Bio Foundries initiative. Founded by a distinguished group of 14 eminent scientists, including renowned chemists, entomologists, and biotechnologists, ATGC has harnessed their profound expertise to revolutionize sustainable agriculture. He is promoter of AACT Inc USA and Bharath Advanced Therapeutics developing new drugs for Cancer Treatment with a multibillion dollar portfolio . He is a serial Entrepreneur and invests in deep tech companies. He Graduated from Nizam College and has a double Master’s Degree in Life Sciences & Chemical Engineering from Osmania University and JNTU. He completed his Ph.D program working for Rockefeller Foundation in Univ. of Hyderabad and went on deputation under Coordinated programs in United Nations Institutes. He contributed to Gen Bank for the first time in the world in Identifying more than 3K genes in Rice and Pearl Millet and deposited the Gen Bank. For past 10 years he specializes in area wide management of insect epidemics around the world. He has developed technologies for pest control using mating disruption as a tool to control insect population. He has worked in award winning programs of DST, DBT BIRAC, USDA, NSF, USAID and USISTEF. His tools will create and open up new markets in pest management.